ArticleCancers2021

Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study.

Henner Stege et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.